BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 28123791)

  • 21. Identification of a De Novo Xq26.2 Microduplication Encompassing
    Miolo G; Bernardini L; Capalbo A; Favia A; Goldoni M; Pivetta B; Tessitori G; Corona G
    Diagnostics (Basel); 2020 Nov; 10(12):. PubMed ID: 33255855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Array CGH analysis of a cohort of Russian patients with intellectual disability.
    Kashevarova AA; Nazarenko LP; Skryabin NA; Salyukova OA; Chechetkina NN; Tolmacheva EN; Sazhenova EA; Magini P; Graziano C; Romeo G; Kučinskas V; Lebedev IN
    Gene; 2014 Feb; 536(1):145-50. PubMed ID: 24291026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dihydropyrimidine Dehydrogenase Deficiency: Homozygosity for an Extremely Rare Variant in DPYD due to Uniparental Isodisomy of Chromosome 1.
    van Kuilenburg ABP; Meijer J; Meinsma R; Pérez-Dueñas B; Alders M; Bhuiyan ZA; Artuch R; Hennekam RCM
    JIMD Rep; 2019; 45():65-69. PubMed ID: 30349988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A variant Cri du Chat phenotype and autism spectrum disorder in a subject with de novo cryptic microdeletions involving 5p15.2 and 3p24.3-25 detected using whole genomic array CGH.
    Harvard C; Malenfant P; Koochek M; Creighton S; Mickelson EC; Holden JJ; Lewis ME; Rajcan-Separovic E
    Clin Genet; 2005 Apr; 67(4):341-51. PubMed ID: 15733271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients.
    Ezzeldin HH; Lee AM; Mattison LK; Diasio RB
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8699-705. PubMed ID: 16361556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microdeletions in 9q33.3-q34.11 in five patients with intellectual disability, microcephaly, and seizures of incomplete penetrance: is STXBP1 not the only causative gene?
    Ehret JK; Engels H; Cremer K; Becker J; Zimmermann JP; Wohlleber E; Grasshoff U; Rossier E; Bonin M; Mangold E; Bevot A; Schön S; Heilmann-Heimbach S; Dennert N; Mathieu-Dramard M; Lacaze E; Plessis G; de Broca A; Jedraszak G; Röthlisberger B; Miny P; Filges I; Dufke A; Andrieux J; Lee JA; Zink AM
    Mol Cytogenet; 2015; 8():72. PubMed ID: 26421060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CNTN6 copy number variations in 14 patients: a possible candidate gene for neurodevelopmental and neuropsychiatric disorders.
    Hu J; Liao J; Sathanoori M; Kochmar S; Sebastian J; Yatsenko SA; Surti U
    J Neurodev Disord; 2015; 7(1):26. PubMed ID: 26257835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case Report: Two New Cases of Chromosome 12q14 Deletions and Review of the Literature.
    Deng R; McCalman MT; Bossuyt TP; Barakat TS
    Front Genet; 2021; 12():716874. PubMed ID: 34539745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA LINC00261 induces chemosensitization to 5-fluorouracil by mediating methylation-dependent repression of DPYD in human esophageal cancer.
    Lin K; Jiang H; Zhuang SS; Qin YS; Qiu GD; She YQ; Zheng JT; Chen C; Fang L; Zhang SY
    FASEB J; 2019 Feb; 33(2):1972-1988. PubMed ID: 30226808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuronal overexpression of Ube3a isoform 2 causes behavioral impairments and neuroanatomical pathology relevant to 15q11.2-q13.3 duplication syndrome.
    Copping NA; Christian SGB; Ritter DJ; Islam MS; Buscher N; Zolkowska D; Pride MC; Berg EL; LaSalle JM; Ellegood J; Lerch JP; Reiter LT; Silverman JL; Dindot SV
    Hum Mol Genet; 2017 Oct; 26(20):3995-4010. PubMed ID: 29016856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
    Chai J; Dong W; Xie C; Wang L; Han DL; Wang S; Guo HL; Zhang ZL
    IUBMB Life; 2015 Mar; 67(3):191-201. PubMed ID: 25873402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genetics of autism.
    Muhle R; Trentacoste SV; Rapin I
    Pediatrics; 2004 May; 113(5):e472-86. PubMed ID: 15121991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular cloning and characterization of the human dihydropyrimidine dehydrogenase promoter.
    Shestopal SA; Johnson MR; Diasio RB
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):162-9. PubMed ID: 11072080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group.
    Schwab M; Zanger UM; Marx C; Schaeffeler E; Klein K; Dippon J; Kerb R; Blievernicht J; Fischer J; Hofmann U; Bokemeyer C; Eichelbaum M;
    J Clin Oncol; 2008 May; 26(13):2131-8. PubMed ID: 18299612
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Gug C; Stoicanescu D; Mozos I; Nussbaum L; Cevei M; Stambouli D; Pavel AG; Doros G
    Front Pediatr; 2020; 8():375. PubMed ID: 32733829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cytogenetic characterization of mosaicism for a small supernumerary marker chromosome derived from chromosome 8 or r(8)(::p11.22→q11.21::) in an 18-year-old female with short stature, obesity, attention deficit hyperactivity disorder, and intellectual disability.
    Chen CP; Lin SP; Chern SR; Wu PS; Chen YN; Chen SW; Yang CW; Lee MS; Wang W
    Taiwan J Obstet Gynecol; 2016 Dec; 55(6):856-860. PubMed ID: 28040133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Siblings with opposite chromosome constitutions, dup(2q)/del(7q) and del(2q)/dup(7q).
    Shim SH; Shim JS; Min K; Lee HS; Park JE; Park SH; Hwang E; Kim M
    Gene; 2014 Jan; 534(1):100-6. PubMed ID: 24095776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 1.37-Mb 12p11.22-p11.21 deletion coincident with a 367-kb 22q11.2 duplication detected by array comparative genomic hybridization in an adolescent girl with autism and difficulty in self-care of menstruation.
    Chen CP; Lin SP; Chern SR; Wu PS; Su JW; Lee CC; Wang W
    Taiwan J Obstet Gynecol; 2014 Mar; 53(1):74-8. PubMed ID: 24767651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting.
    Gokare P; Finnberg NK; Abbosh PH; Dai J; Murphy ME; El-Deiry WS
    Sci Rep; 2017 Aug; 7(1):9711. PubMed ID: 28851987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant methylation of DPYD promoter, DPYD expression, and cellular sensitivity to 5-fluorouracil in cancer cells.
    Noguchi T; Tanimoto K; Shimokuni T; Ukon K; Tsujimoto H; Fukushima M; Noguchi T; Kawahara K; Hiyama K; Nishiyama M
    Clin Cancer Res; 2004 Oct; 10(20):7100-7. PubMed ID: 15501990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.